TriaGen Wealth Management LLC Has $358,000 Stock Holdings in Axon Enterprise, Inc $AXON

TriaGen Wealth Management LLC decreased its holdings in shares of Axon Enterprise, Inc (NASDAQ:AXON) by 88.5% in the 2nd quarter, HoldingsChannel.com reports. The fund owned 433 shares of the biotechnology company’s stock after selling 3,321 shares during the quarter. TriaGen Wealth Management LLC’s holdings in Axon Enterprise were worth $358,000 at the end of the most recent quarter.

A number of other large investors also recently made changes to their positions in AXON. LaSalle St. Investment Advisors LLC lifted its stake in Axon Enterprise by 2.1% in the first quarter. LaSalle St. Investment Advisors LLC now owns 777 shares of the biotechnology company’s stock valued at $408,000 after buying an additional 16 shares in the last quarter. Smartleaf Asset Management LLC increased its position in shares of Axon Enterprise by 5.0% during the first quarter. Smartleaf Asset Management LLC now owns 379 shares of the biotechnology company’s stock worth $203,000 after acquiring an additional 18 shares in the last quarter. Pinion Investment Advisors LLC raised its holdings in shares of Axon Enterprise by 3.0% during the first quarter. Pinion Investment Advisors LLC now owns 649 shares of the biotechnology company’s stock worth $341,000 after acquiring an additional 19 shares during the period. Kentucky Retirement Systems lifted its position in Axon Enterprise by 0.4% in the 1st quarter. Kentucky Retirement Systems now owns 4,953 shares of the biotechnology company’s stock valued at $2,605,000 after acquiring an additional 19 shares in the last quarter. Finally, WCM Investment Management LLC boosted its stake in Axon Enterprise by 0.8% in the 1st quarter. WCM Investment Management LLC now owns 2,441 shares of the biotechnology company’s stock worth $1,306,000 after purchasing an additional 19 shares during the period. Institutional investors and hedge funds own 79.08% of the company’s stock.

Wall Street Analyst Weigh In

A number of brokerages have recently commented on AXON. UBS Group restated a “neutral” rating and issued a $840.00 price target (up from $820.00) on shares of Axon Enterprise in a report on Tuesday, August 5th. Northland Securities set a $800.00 price objective on Axon Enterprise in a research report on Tuesday, August 5th. Raymond James Financial restated an “outperform” rating and set a $855.00 target price (up previously from $645.00) on shares of Axon Enterprise in a research note on Tuesday, August 5th. Morgan Stanley set a $885.00 price target on shares of Axon Enterprise and gave the company an “overweight” rating in a research note on Friday, July 11th. Finally, Wolfe Research started coverage on shares of Axon Enterprise in a report on Monday, July 7th. They issued an “outperform” rating on the stock. Fourteen analysts have rated the stock with a Buy rating and four have issued a Hold rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $841.64.

Insider Buying and Selling

In other Axon Enterprise news, CAO Jennifer H. Mak sold 77 shares of the firm’s stock in a transaction on Monday, September 15th. The stock was sold at an average price of $760.00, for a total transaction of $58,520.00. Following the transaction, the chief accounting officer owned 15,003 shares in the company, valued at $11,402,280. This trade represents a 0.51% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, President Joshua Isner sold 15,919 shares of the company’s stock in a transaction on Friday, August 15th. The shares were sold at an average price of $746.26, for a total value of $11,879,712.94. Following the sale, the president owned 238,379 shares of the company’s stock, valued at approximately $177,892,712.54. The trade was a 6.26% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 49,932 shares of company stock valued at $37,978,216 in the last quarter. Corporate insiders own 4.40% of the company’s stock.

Axon Enterprise Trading Up 0.8%

Shares of Axon Enterprise stock opened at $721.59 on Tuesday. The company has a debt-to-equity ratio of 0.63, a quick ratio of 2.71 and a current ratio of 2.95. The firm has a 50-day moving average of $757.50 and a 200-day moving average of $710.51. Axon Enterprise, Inc has a 52-week low of $416.88 and a 52-week high of $885.91. The stock has a market cap of $56.65 billion, a PE ratio of 178.17, a PEG ratio of 27.79 and a beta of 1.41.

Axon Enterprise (NASDAQ:AXON) last issued its quarterly earnings data on Monday, August 4th. The biotechnology company reported $2.12 earnings per share for the quarter, topping the consensus estimate of $1.54 by $0.58. The business had revenue of $668.54 million during the quarter, compared to analysts’ expectations of $641.77 million. Axon Enterprise had a net margin of 13.64% and a return on equity of 6.80%. The business’s revenue was up 32.6% on a year-over-year basis. During the same quarter in the previous year, the company earned $1.20 EPS. Axon Enterprise has set its FY 2025 guidance at EPS. As a group, sell-side analysts forecast that Axon Enterprise, Inc will post 5.8 EPS for the current year.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.